These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 32299907)
21. RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study. Shen L; Zhu J; Chen F; Lin W; Cai J; Zhong J; Zhong H BMC Cancer; 2015 Dec; 15():970. PubMed ID: 26674644 [TBL] [Abstract][Full Text] [Related]
23. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript. Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486 [TBL] [Abstract][Full Text] [Related]
24. RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis. Lam K; Zhang DE Front Biosci (Landmark Ed); 2012 Jan; 17(3):1120-39. PubMed ID: 22201794 [TBL] [Abstract][Full Text] [Related]
25. Glucocorticoids Inhibit Oncogenic RUNX1-ETO in Acute Myeloid Leukemia with Chromosome Translocation t(8;21). Lu L; Wen Y; Yao Y; Chen F; Wang G; Wu F; Wu J; Narayanan P; Redell M; Mo Q; Song Y Theranostics; 2018; 8(8):2189-2201. PubMed ID: 29721072 [TBL] [Abstract][Full Text] [Related]
26. The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells. Maicas M; Vázquez I; Alis R; Marcotegui N; Urquiza L; Cortés-Lavaud X; Cristóbal I; García-Sánchez MA; Odero MD Biochim Biophys Acta Gene Regul Mech; 2017 Jun; 1860(6):721-729. PubMed ID: 28391050 [TBL] [Abstract][Full Text] [Related]
27. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684 [TBL] [Abstract][Full Text] [Related]
28. AML1 mutations induced MDS and MDS/AML in a mouse BMT model. Watanabe-Okochi N; Kitaura J; Ono R; Harada H; Harada Y; Komeno Y; Nakajima H; Nosaka T; Inaba T; Kitamura T Blood; 2008 Apr; 111(8):4297-308. PubMed ID: 18192504 [TBL] [Abstract][Full Text] [Related]
29. Truncated RUNX1 protein generated by a novel t(1;21)(p32;q22) chromosomal translocation impairs the proliferation and differentiation of human hematopoietic progenitors. Rodriguez-Perales S; Torres-Ruiz R; Suela J; Acquadro F; Martin MC; Yebra E; Ramirez JC; Alvarez S; Cigudosa JC Oncogene; 2016 Jan; 35(1):125-34. PubMed ID: 25798834 [TBL] [Abstract][Full Text] [Related]
30. A 5' untranslated region containing the IRES element in the Runx1 gene is required for angiogenesis, hematopoiesis and leukemogenesis in a knock-in mouse model. Nagamachi A; Htun PW; Ma F; Miyazaki K; Yamasaki N; Kanno M; Inaba T; Honda Z; Okuda T; Oda H; Tsuji K; Honda H Dev Biol; 2010 Sep; 345(2):226-36. PubMed ID: 20647008 [TBL] [Abstract][Full Text] [Related]
31. [Study of genes involved in chronic myeloid leukemia with t (3; 21) (q26; q22) in blastic crisis]. Liu XP; Zhang MR; Dai Y; Zhang L; Li R; Hao YS; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):310-3. PubMed ID: 16875579 [TBL] [Abstract][Full Text] [Related]
32. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia. Engel ME; Hiebert SW Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249 [TBL] [Abstract][Full Text] [Related]
33. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression. Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595 [TBL] [Abstract][Full Text] [Related]
34. Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia. Ottema S; Mulet-Lazaro R; Beverloo HB; Erpelinck C; van Herk S; van der Helm R; Havermans M; Grob T; Valk PJM; Bindels E; Haferlach T; Haferlach C; Smeenk L; Delwel R Blood; 2020 Jul; 136(2):224-234. PubMed ID: 32219447 [TBL] [Abstract][Full Text] [Related]
35. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice. Cuenco GM; Ren R Oncogene; 2004 Jan; 23(2):569-79. PubMed ID: 14724585 [TBL] [Abstract][Full Text] [Related]
36. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator. Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573 [TBL] [Abstract][Full Text] [Related]
37. Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements. Sitailo S; Sood R; Barton K; Nucifora G Leukemia; 1999 Nov; 13(11):1639-45. PubMed ID: 10557037 [TBL] [Abstract][Full Text] [Related]
38. Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders. Metzeler KH; Bloomfield CD Adv Exp Med Biol; 2017; 962():175-199. PubMed ID: 28299658 [TBL] [Abstract][Full Text] [Related]
39. EVI1 and GATA2 misexpression induced by inv(3)(q21q26) contribute to megakaryocyte-lineage skewing and leukemogenesis. Yamaoka A; Suzuki M; Katayama S; Orihara D; Engel JD; Yamamoto M Blood Adv; 2020 Apr; 4(8):1722-1736. PubMed ID: 32330245 [TBL] [Abstract][Full Text] [Related]
40. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia. Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]